These findings establish a regulatory link between inflammatory signaling and adipocyte metabolism and suggest that the IL18 signaling from NCC and IL18r in different adipose tissues (Fig. 10) represents distinct therapeutic approaches to protect against thermogenesis-defect-associated energy expenditure and obesity and insulin signaling defect-associated diabetes. This evidence concerns the gene IL18R1 and diabetes mellitus.